BnH Research Overview
- Year Founded
-
2015

- Status
-
Private
- Employees
-
14

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$9.9M
- Investors
-
10
BnH Research General Information
Description
Operator of a drug development and research firm designed to verify the efficacy of new drug candidates or developed drugs and improve the lives of patients suffering from chronic conditions. The company engages in providing contract-based research services to validate the data of drug efficacy to fill the unmet needs of pharmaceutical companies and also develops drug candidates with special emphasis on reopening cortical plasticity, enabling clients to develop new drugs and help in targeting CNS conditions, including Alzheimer's Disease (AD), PTSD (Post Traumatic Stress Disorder), addiction, amblyopia, and stroke.
Contact Information
Website
www.bnhresearch.netCorporate Office
- 705, Mega City, 188 Chuncheon-ro
- Chuncheon, Gangwon
- South Korea
Corporate Office
- 705, Mega City, 188 Chuncheon-ro
- Chuncheon, Gangwon
- South Korea
BnH Research Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series B) | 18-Mar-2022 | $9.9M | Completed | Clinical Trials - Phase 1 | ||
4. Later Stage VC (Series A) | 29-May-2020 | Completed | Clinical Trials - Phase 1 | |||
3. Seed Round | 30-Apr-2019 | Completed | Pre-Clinical Trials | |||
2. Early Stage VC | 01-Apr-2017 | Completed | Pre-Clinical Trials | |||
1. Seed Round | 01-Dec-2016 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BnH Research Patents
BnH Research Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023244908-A1 | Nitrogen-containing heterocyclic compounds and uses thereof | Pending | 28-Mar-2022 | ||
EP-4501910-A1 | Nitrogen-containing heterocyclic compounds and uses thereof | Pending | 28-Mar-2022 | ||
EP-4501911-A1 | Nitrogen-containing heterocyclic compounds having phenyl group and uses thereof | Pending | 28-Mar-2022 | ||
JP-2025511114-A | Nitrogen-containing heterocyclic compounds and their uses | Pending | 28-Mar-2022 | ||
JP-2025512899-A | Nitrogen-containing heterocyclic compound having a phenyl group and its use | Pending | 28-Mar-2022 |
BnH Research Signals
BnH Research Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
CKD Venture Capital | Corporate Venture Capital | Minority | ||
Ernest Ventures | Venture Capital | Minority | ||
P&P Investment | Venture Capital | Minority | ||
We Ventures (Korea) | Venture Capital | Minority | ||
Albatross Investment | Venture Capital | Minority |
BnH Research FAQs
-
When was BnH Research founded?
BnH Research was founded in 2015.
-
Where is BnH Research headquartered?
BnH Research is headquartered in Chuncheon, South Korea.
-
What is the size of BnH Research?
BnH Research has 14 total employees.
-
What industry is BnH Research in?
BnH Research’s primary industry is Drug Discovery.
-
Is BnH Research a private or public company?
BnH Research is a Private company.
-
What is BnH Research’s current revenue?
The current revenue for BnH Research is
. -
How much funding has BnH Research raised over time?
BnH Research has raised $14.4M.
-
Who are BnH Research’s investors?
CKD Venture Capital, Ernest Ventures, P&P Investment, We Ventures (Korea), and Albatross Investment are 5 of 10 investors who have invested in BnH Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »